A Tumor-Targeting Nanomedicine Carrying the P53 Gene Crosses the Blood-Brain Barrier and Enhances Anti-Pd-1 Immunotherapy in Mouse Models of Glioblastoma

International Journal of Cancer - United States
doi 10.1002/ijc.32531
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Nanoprobe Crosses Blood-Brain Barrier to Image and Treat Tumor

MRS Bulletin
Materials ScienceTheoretical ChemistryCondensed Matter PhysicsPhysical
2009English

FcγRs Modulate the Anti-Tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis

Cancer Cell
Cancer ResearchOncologyCell Biology
2015English

Genetic Mouse Models to Study Blood–brain Barrier Development and Function

Fluids and Barriers of the CNS
MedicineMolecular NeuroscienceNeurologyDevelopmental NeuroscienceCellular
2013English

Tumor Immunotherapy Directed at PD-1

New England Journal of Medicine
Medicine
2012English

Targeting Neurotherapeutic Agents Through the Blood-Brain Barrier

Archives of Neurology
2002English

A Tumor-Targeting P53 Nanodelivery System Limits Chemoresistance to Temozolomide Prolonging Survival in a Mouse Model of Glioblastoma Multiforme

Nanomedicine: Nanotechnology, Biology, and Medicine
Materials ScienceMolecular MedicineNanosciencePharmaceutical ScienceMedicineBioengineeringNanotechnologyBiomedical Engineering
2015English

Understanding the Physiology of the Blood-Brain Barrier: In Vitro Models

Physiology
Physiology
1998English

New Perspective on Targeting the Tumor Suppressor P53 Pathway in the Tumor Microenvironment to Enhance the Efficacy of Immunotherapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Dissecting Gene Expression at the Blood-Brain Barrier

Frontiers in Neuroscience
Neuroscience
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy